Skip to content

Clinical trials

Phase 2 Fallopian Tube Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 2 Country / region: Germany Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20062
20071
20131
20182
20191
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGO Study Group4
North Eastern German Society of Gynaecological Oncology2
Corcept Therapeutics1
Eli Lilly and Company1
Fore Biotherapeutics1
Glycotope GmbH1
Imperial College London1
Mario Negri Institute for Pharmacological Research1
Morphotek1
TORL Biotherapeutics, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms15
Ovarian Neoplasms13
Peritoneal Neoplasms4
Carcinoma, Ovarian Epithelial3
Neoplasms3
Adenocarcinoma, Clear Cell1
Anemia1
Biliary Tract Neoplasms1
Breast Neoplasms1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.